- Breast cancer is the cancer with the highest incidence with 2.26 million new cases each year.
- In contrast, lung cancer is the deadliest, causing 1.8 million deaths annually.
- The objective of this new agreement is the implementation of cell therapy in leukemias and lymphomas as a more efficient treatment against cancer.
Tumors remain one of the main causes of death in the world. In 2020 alone, they were responsible for nine million deaths and the trend continues to rise. For this reason, new techniques are constantly being developed, such as cancer cell therapy with which it seeks to achieve the recovery of patients.
In this sense, one of the most important aspects to overcome the disease is the early detection. When it occurs in its early stages there is a better chance of success. Therefore, regular reviews are essential to identify any signs as soon as possible.
The union to achieve better results
Based on all of the above, the National Polytechnic Institute (IPN) and the National Institute of Medical Sciences and Nutrition “Salvador Zubirán” (INCMNSZ) formalized a general collaboration agreement. The objective is the implementation of cell therapy in leukemias and lymphomas as a more efficient treatment against cancer.
The agreement includes the implementation of academic exchange projects and the training of human resources for health care. Also the promotion of scientific and clinical research and the creation of biotherapeutic treatments for the benefit of the population.
Promote the development of doctors of excellence
In this regard, the head of the IPN, Arturo Reyes Sandoval, said that the INCMNSZ is an example in the training of doctors of excellence and in the study of medicine and scientific research.
“It has trained doctors who have left a deep mark in Mexico and the world for their contributions and discoveries, as well as for the implementation of the contraceptive pill, which has permeated the entire world.”
He assured that both institutions work on projects of national and international relevance. Some examples are the development of methodologies against cancer, more efficient and with state-of-the-art methods.
He also commented that the first contact with the INCMNSZ took place during the working visit of both institutions to India, which was led by the Ministry of Foreign Affairs (SRE) with the support of the Mexican Agency for International Development Cooperation ( AMEXCID).
He stressed that the Polytechnic has a great history in the training of doctors and biotechnologists. Some even work in specialized areas of the Salvador Zubirán Institute, for which he trusted that the agreement will help achieve the best results.
For his part, the director general of the INCMNSZ, David Kershenobich Stalnikowitz, thanked the IPN for the opportunity to sign this agreement which he described as a watershed in a very fruitful relationship for the country.
“The INCMNSZ has 199 full-time researchers who are eager to participate and offer their expertise in the field of health care.”
He explained that in this time of the COVID-19 pandemic, technological advances are very important. He referred that primary health care will be radically transformed, because with technology it will not be limited to primary care but personalized or high-precision medicine will be applied.